apple is investing $ 115 m in a partnership with Arvinas , aimed at developing the biotech firm 's protein degradation inhibitor Proteolysis - Targeting Chimera ( gene ) , for use in human and agricultural products . The partners will also work together to develop new agricultural products ; they plan to use PROTAC to prevent a virus linked to a disease by treating it with engineered molecules .
Bayer is investing $115m in a partnership with Arvinas, aimed at developing the biotech firm's protein degradation technology Proteolysis-Targeting Chimera (PROTAC), for use in human and agricultural products. The companies will also work together to develop new agricultural products; they plan to use PROTAC to eliminate a protein linked to a disease by tagging it with engineered molecules.